Linked Life Data

3499170

Source:http://linkedlifedata.com/resource/pubmed/id/3499170

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3499170rdf:typepubmed:Citationlld:pubmed
pubmed-article:3499170lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:3499170lifeskim:mentionsumls-concept:C0014822lld:lifeskim
pubmed-article:3499170lifeskim:mentionsumls-concept:C0021755lld:lifeskim
pubmed-article:3499170lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:3499170lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:3499170lifeskim:mentionsumls-concept:C0178416lld:lifeskim
pubmed-article:3499170lifeskim:mentionsumls-concept:C0699748lld:lifeskim
pubmed-article:3499170lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:3499170lifeskim:mentionsumls-concept:C1516960lld:lifeskim
pubmed-article:3499170lifeskim:mentionsumls-concept:C1709634lld:lifeskim
pubmed-article:3499170pubmed:issue1lld:pubmed
pubmed-article:3499170pubmed:dateCreated1987-12-16lld:pubmed
pubmed-article:3499170pubmed:abstractTextHighly purified and cloned preparations of interleukin-1 (IL-1) were found to antagonize the capacity of erythropoietin (Epo) to stimulate the proliferation of mouse spleen and bone marrow erythroid precursor cells (EPC) in culture. Cloned murine IL-1 and purified and cloned human IL-1 alpha and IL-1 beta were approximately equipotent in this assay. IL-1 inhibited the proliferation response of EPC even when added as long as 17 h after Epo, suggesting that IL-1 does not affect binding of Epo to receptors or biochemical events following shortly thereafter. Indomethacin did not influence the inhibitory effect of IL-1 on Epo-induced proliferation, and PGE2 had no demonstrable effect on the process. Tumor-necrosis factor-alpha and interferons beta 1, and gamma did not affect Epo-induced proliferation. It is suggested that IL-1 mediated antagonism of the effects of Epo on erythroid precursors is a factor in the pathogenesis of many types of hypoplastic anaemia, including those associated with infections, rheumatoid arthritis and systemic lupus erythematosus, giant-cell arteritis, graft-versus-host disease and disorders associated with lymphocyte-mediated suppression of erythropoiesis.lld:pubmed
pubmed-article:3499170pubmed:languageenglld:pubmed
pubmed-article:3499170pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3499170pubmed:citationSubsetIMlld:pubmed
pubmed-article:3499170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3499170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3499170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3499170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3499170pubmed:statusMEDLINElld:pubmed
pubmed-article:3499170pubmed:monthSeplld:pubmed
pubmed-article:3499170pubmed:issn0007-1048lld:pubmed
pubmed-article:3499170pubmed:authorpubmed-author:SchooleyJ CJClld:pubmed
pubmed-article:3499170pubmed:authorpubmed-author:AllisonA CAClld:pubmed
pubmed-article:3499170pubmed:authorpubmed-author:KullgrenBBlld:pubmed
pubmed-article:3499170pubmed:issnTypePrintlld:pubmed
pubmed-article:3499170pubmed:volume67lld:pubmed
pubmed-article:3499170pubmed:ownerNLMlld:pubmed
pubmed-article:3499170pubmed:authorsCompleteYlld:pubmed
pubmed-article:3499170pubmed:pagination11-7lld:pubmed
pubmed-article:3499170pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:meshHeadingpubmed-meshheading:3499170-...lld:pubmed
pubmed-article:3499170pubmed:year1987lld:pubmed
pubmed-article:3499170pubmed:articleTitleInhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias.lld:pubmed
pubmed-article:3499170pubmed:affiliationDivision of Biology and Medicine, Lawrence Berkeley Laboratory, University of California, Berkeley.lld:pubmed
pubmed-article:3499170pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3499170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3499170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3499170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3499170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3499170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3499170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3499170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3499170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3499170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3499170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3499170lld:pubmed